RHT — Resonance Health Cashflow Statement
0.000.00%
- AU$16.10m
- AU$16.92m
- AU$11.16m
- 44
- 55
- 16
- 31
Annual cashflow statement for Resonance Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.353 | 0.03 | 0.092 | 0.229 | 0.09 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1.17 | -1.46 | -0.157 | 1.39 | 1.25 |
Capital Expenditures | -0.396 | -0.704 | -0.468 | -0.377 | -0.623 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | -3.56 | -3.89 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.396 | -0.704 | -0.468 | -3.94 | -4.52 |
Financing Cash Flow Items | 0 | -0.037 | 0 | -0.036 | -0.043 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.19 | -0.107 | -0.082 | 3.01 | -0.649 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.88 | -2.07 | -0.422 | 0.493 | -3.88 |